PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jorthsurgBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleJournal of Orthopaedic Surgery and ResearchJournal Front Page
 
J Orthop Surg Res. 2010; 5: 57.
Published online 2010 August 16. doi:  10.1186/1749-799X-5-57
PMCID: PMC2933710

An in vivo evaluation of bone response to three implant surfaces using a rabbit intramedullary rod model

Abstract

Our study was designed to evaluate osseointegration among implants with three surface treatments: plasma-sprayed titanium (P), plasma-sprayed titanium with hydroxyapatite (PHA), and chemical-textured titanium with hydroxyapatite (CHA). Average surface roughness (Ra) was 27 microns for the P group, 17 microns for the PHA group, and 26 microns for the CHA group. Bilateral distal intramedullary implants were placed in the femora of thirty rabbits. Histomorphometry of scanning electron microscopy images was used to analyze the amount of bone around the implants at 6 and 12 weeks after implantation. Greater amounts of osseointegration were observed in the hydroxyapatite-coated groups than in the noncoated group. For all implant surfaces, osseointegration was greater at the diaphyseal level compared to the metaphyseal level. No significant differences were seen in osseointegration between the 6 and 12 week time points. Although the average surface roughness of the P and the CHA groups was similar, osseointegration of the CHA implants was significantly greater. The results of this in vivo lapine study suggest that the presence of an hydroxyapatite coating enhances osseointegration despite similarities in average surface roughness.

Introduction

Total hip arthroplasty (THA) is a relatively common procedure that typically results in increased comfort, mobility, pain relief, and alleviation of disability. Once thought to be appropriate for patients between 60 and 75 years of age, the age range for primary THA now often includes a substantially younger population [1-4]. The procedure has an excellent clinical outcome and often restores functional capacity to a large degree. However, aseptic loosening of the components continues to limit the longevity of THA, especially in younger more active patients [1-11]. With the increase in life expectancy and the increase in younger patients undergoing primary THA, the need to extend the longevity of THA is essential.

Non-cemented THA offers the potential for integration of the implant surface with the surrounding bone. Hydroxyapatite coatings have proven effective in providing excellent short- and intermediate-term outcomes in terms of fixation, stability, function, and pain relief [12-17]. Hydroxyapatite coatings enhance osteoblast attachment, proliferation, and differentiation (see Beck for review [18]). While hydroxyapatite is generally considered to be an osteoconductive material, it has occasionally been shown to have osteoinductive properties, which have been attributed to the adsorption of bone morphogenetic proteins [19].

Osteoblastic activity is modulated by surface roughness and is enhanced when the Ra is between 1 and 7 μm [20,21]. In addition, surface roughness in vivo is an important factor affecting bone apposition and mechanical strength of the implant-bone interface. Increasing surface roughness by grit-blasting or chemical-etching has been associated with increased osseointegration in a variety of animal models [22-25].

Since hydroxyapatite coating can alter surface roughness, it is important to determine the relative significance of the individual contributions of these factors [22,26]. For example, superior osseointegration was found in hydroxyapatite-coated trabecular implants in miniature pigs compared to grit-blasted or acid-etched surface [25]. However, the hydroxyapatite-coated implants had a significantly greater Ra. It has not been conclusively shown whether surface roughness or hydroxyapatite coating is the dominant factor affecting in vivo osseointegration. One study concluded that surface roughness contributed more to increased bone apposition rates than hydroxyapatite coating [26]. On the other hand another study found significantly increased bone apposition in hydroxyapatite-coated implants despite comparable surface roughness measures between coated and uncoated implants [27]. We therefore designed a study to investigate the factors contributing to osseointegration in orthopedically relevant surfaces. The study hypothesis was that the addition of a hydroxyapatite coating would enhance osseointegration beyond that provided by change in surface roughness alone.

Methods

Implants for intramedullary implantation in rabbit femora were manufactured and sterilized by Stryker Orthopaedics, Mahwah, NJ. Each implant consisted of a cylinder 5 mm in diameter and 25 mm in length (Figure (Figure1).1). One of three surface treatments was applied to each implant: plasma-sprayed titanium (P), plasma-sprayed titanium with hydroxyapatite (PHA), or chemical-textured titanium with hydroxyapatite (CHA). The hydroxyapatite coating was applied by plasma spraying high purity hydroxyapatite powders with tightly controlled particle size using Sulzer Metco Plasma Spray System. HA powders were injected with Argon as the carrier gas to produce coating with thickness ranging from 40-70 microns (nominal 50 microns). The coating had a minimum total crystallinity of 65%. The minimum HA fraction in the crystalline phase was 90%. The average tensile and shear strength of the coating were ≥ 34 MPa and ≥17 MPa respectively. The chemical texturing was performed by repetitive masking (with an acid resistant mask) and chemical milling with nitric and hydrofluoric acid. The details regarding the chemical texturing process and the osseointegration of chemical-textured implants have been previously reported [22]. Implant surface roughness was measured with a Sheffield Profilometer (Sheffield, Fond du Lac, WI).

Figure 1
Photographs of implant surfaces. P = plasma-sprayed titanium (mean Ra = 27 microns); PHA = plasma-sprayed titanium with plasma-sprayed hydroxyapatite coating (mean Ra = 17 microns); CHA = chemical-textured titanium surface (by acid etching) with hydroxyapatite ...

Thirty adult male New Zealand White rabbits were used in our study. After institutional review board approval, rabbits underwent bilateral femoral intramedullary implantation under general anesthesia. All animals received Buprenorphine 0.03 mg/Kg IM immediately postoperatively, and 0.01 mg/Kg IM every 12 hours for three days. After that any animal demonstrating pain or discomfort received Buprenorphine 0.01 mg/Kg IM. All animals were allowed unrestricted cage activity, and food and water ad libitum. Temperature was maintained at 24°C and humidity at 70%. All rabbits tolerated the anesthesia and surgical procedure uneventfully. Recovery was quick and rabbits were usually ambulating without noticeable limp by postoperative day 7. One rabbit developed intestinal obstruction after ingesting surgical dressing and was euthanized 6 days before schedule. The femora were harvested from this rabbit and included in the SEM analysis.

The details of this in vivo rabbit model have been described previously (Figure (Figure2)2) [22,28]. The appropriate experimental implant was press-fit into the intramedullary canal through a drill hole in the intercondylar notch of the femur. Bilateral implantation was used to reduce any bias introduced by unilateral implantation because the animal might favor the operated limb. Implants were distributed by type between limbs to permit paired comparison with an equal number of pairs per time point (P vs PHA, P vs CHA, and PHA vs CHA). Fifteen rabbits were euthanized postoperatively at 6 weeks; 15 at 12 weeks. At euthanasia, bilateral distal femora were harvested, cleaned of soft tissue, and fixed in 70% ethanol.

Figure 2
Diagram of intramedullary implantation. The implanted bone was sectioned at three levels shown.

The femur bone was trimmed above and below the ends of the implant, cleaned of soft-tissue, and fixed in 70% alcohol. The specimen was further dehydrated in absolute alcohol and de-fatted in 50% mixture of ether and acetone before being placed in 100% alcohol again for 12 hours. The specimen was then embedded in methyl methacrylate and transverse sections nominally 1-mm thick cut with a diamond wafering blade at three levels, approximately coinciding with the distal third of the femoral diaphysis, the distal femoral metaphysis, and a level midway between the two. Backscatter electron images were obtained using a scanning electron microscope (JEOL 35, JEOL Ltd, Tokyo, Japan) at 40 × magnifications, 25-KeV beam voltage, and 100 μA emission current at a working distance of 15 mm. Images were of the implant-bone interface were captured around the perimeter of the implant and stored in 8-bit grayscale format at a resolution of 128 pixels per mm (pixel size 7.8 μm).

Automated computerized image analysis was performed on the SEM images using a previously validated approach [22,29]. A custom script was written (MATLAB, Image Processing Toolbox, MathWorks, Natick, MA). The image was segmented into bone and implant regions based on the trimodal histogram of the image. Images were initially filtered to remove random stray pixels. The image was segmented into three areas represented by: implant pixels (grayscale value between 200 and 255), bone pixels (grayscale value between 80 and 200), and soft-tissue pixels (grayscale value between 0 and 80). An edge detection algorithm was used to detect pixels at the perimeter of the implant and the bone and soft-tissue pixels adjacent to the edge of the implants were counted.

Osseointegration was defined as bone-to-implant contact and calculated as the ratio of the number of bone pixels relative to the total number of pixels (bone + soft tissue) at the perimeter of the implant. Additionally, the relative numbers of bone pixels were measured at varying distances (up to 0.24 mm) radially outward from the perimeter of the implant to detect changes in patterns of bone growth among the different surfaces.

Power analysis determined that a sample size of 10 was adequate to detect differences in osseointegration of greater than 15% among groups with a power greater than 80% and an alpha of 0.05, assuming a standard deviation of up to 11%. Results from four quadrants were averaged to obtain the net osseointegration and presence of bone for each section level.

Multifactorial two-way Analyses of Variance (ANOVA) were performed on mean osseointegration (or presence of bone at 0.03 to 0.24 mm from the implant surface) with surface treatment, time after surgery, and bone section level as the variables. When statistical differences were identified, Tukey post hoc pairwise comparisons were performed. Significant differences were assumed at p ≤ 0.05.

Results

Mean surface roughness (Ra) was 27 microns for the P group, 17 microns for the PHA group, and 26 microns for the CHA group (statistically different between the P and PHA groups and between the P and CHA groups). Representative SEM images of osseointegration for the three surfaces are shown in Figure Figure3.3. ANOVA indicated significant differences in osseointegration as a function of both section level and surface treatment. Mean osseointegration was significantly higher in the CHA (74 ± 15%) and PHA (64 ± 14%) groups as compared to the P group (39 ± 17%) (Figure (Figure4).4). When all implant surfaces were pooled together, osseointegration at the diaphyseal level (69 ± 18%) was significantly greater than at both the intermediate (53 ± 22%) and metaphyseal levels (56 ± 19%). However, the differences in osseointegration along the axial direction were statistically similar between surface treatments (i.e., diaphyseal osseointegration was greater for all implant surfaces). No significant differences between 6 week and 12 week data were observed (Figure (Figure55).

Figure 3
Representative SEM images are shown depicting the range of low and high osseointegration for each surface. A: Plasma-sprayed titanium surface (P) showing 0% osseointegration (intermediate level, posterior quadrant). B: Plasma-sprayed titanium surface ...
Figure 4
Mean osseointegration (with standard deviation bars) was plotted for each paired comparison. Data from 6 and 12 week time points were pooled. The hydroxyapatite-coated groups (PHA and CHA) consistently resulted in higher levels of osseointegration than ...
Figure 5
Mean osseointegration (with standard deviation bars) was plotted for each group at the 6-week and 12-week time points. No significant differences between time points were noted.

ANOVA also indicated significant differences in presence of bone radially outward from the perimeter of the implant. These differences were also related to both section level and surface treatment, with no time effect. Significantly greater bone was present within 0.03 mm of the implant surface was observed in the hydroxyapatite-coated groups (Figure (Figure6).6). However, from 0.03 to 0.24 mm no further differences in presence of bone were noted as a function of surface treatment. Significant differences in presence of bone among bone section levels were also observed and these differences remained constant throughout the 0.24 mm distance from the implant perimeter evaluated. The presence of bone in the radial direction at the diaphyseal and metaphyseal levels was significantly higher than at the intermediate level. No significant differences in presence of bone were observed between 6 and 12 weeks.

Figure 6
Percentage of bone plotted as a function of distance from implant surface. Six and 12 week data are pooled for each group. Bone growth was higher within 0.03 mm of the implant surface in the hydroxyapatite-coated groups compared to the uncoated group. ...

Discussion

The intramedullary bone response to three titanium surfaces (grit-blasted, porous fiber mesh, and acid-etched) was previously evaluated using the same animal model [22]. In that study, the chemically textured (by acid-etching) surface with a Ra of 18 microns showed higher osseointegration than the grit-blasted surface with and Ra of 6 microns. This study builds on our previous findings by investigating the effect of hydroxyapatite coating on surfaces with different roughness. The PHA and CHA groups had very different Ra values of 17 microns and 26 microns, respectively, yet the osseointegration of each hydroxyapatite-coated surface was comparable, which suggested that the presence of the osteoinductive hydroxyapatite coating had a greater influence on bone growth than the surface roughness. Conversely, the mean Ra values for the P and CHA groups were very similar at 27 microns and 26 microns, respectively. However, the osseointegration and distribution of bone were significantly different between these two groups.

Both surface roughness and hydroxyapatite coating have been shown to increase osseointegration [30]. Some reports have attributed increased osseointegration to surface roughness [23,31,32] while other reports to the hydroxyapatite coating [33-36]. Since the hydroxyapatite coating alters the surface roughness, a few studies have attempted to quantify the relative contribution of surface topography versus hydroxyapatite coating. Carlsson et al implanted titanium implants in the upper tibia of osteoarthritic knees of patients scheduled for total knee arthroplasty [37]. The osseointegration reported at 3 months was significantly higher in grit-blasted implants (mean Ra = 3.1) than in implants with a smooth surface (mean Ra = 0.9). This osseointegration was similar to that seen in implants coated with hydroxyapatite (mean Ra = 5.1). However, the sample size studied was small with a large variance in the reported data. In a more controlled canine femoral intramedullary model, Hacking et al determined the relative contributions of surface chemistry and topography on osseointegration [26]. The hydroxyapatite surface of one group of implants was coated with a thin film of titanium, which masked the chemical activity of the hydroxyapatite coat while retaining the topography and surface roughness. Mean osseointegration of hydroxyapatite-coated implants (74%) was higher than the masked hydroxyapatite group (59%) or the grit-blasted group (23%). The relative increase in osseointegration between masked hydroxyapatite implants and grit-blasted implants was larger than the increase in osseointegration between hydroxyapatite-coated and masked hydroxyapatite implants. The authors therefore concluded that surface topography was the dominant factor influencing bone growth.

On the other hand, our study found a stronger correlation between the presence of hydroxyapatite and osseointegration than between surface roughness and osseointegration. In our study, the surface roughness of the implants used ranged from a Ra of 17 to 26 microns. The surface roughness of the implants tested by Carlsson et al and Hacking et al were in the 3 to 6 micron range. It is therefore possible that an interaction effect exists between surface roughness and hydroxyapatite coating on osseointegration. At higher magnitudes of surface roughness, the hydroxyapatite coating may contribute more to osseointegration. The differences in findings underscore the need for additional research to better understand the processes that influence osseointegration.

Osseointegration was significantly higher at the diaphyseal level compared to that at the metaphyseal or intermediate levels. Implant-bone contact as well the type of bone (trabecular versus lamellar) varies along the axial direction. However, the differences in osseointegration along the axial direction were statistically similar between surface treatments. This suggests an absence of interaction effect between surface chemistry and location of implant. The presence of bone in the radial direction also varied by implant surface. Significantly greater bone was present within 0.03 mm of the implant surface in the hydroxyapatite-coated groups. While the SEM could not differentiate between newly deposited bone and pre-existing bone, these differences near the implant-bone surface were likely due to new bone formation.

The similarity in the chemistry of the hydroxyapatite coating with the crystalline phase of bone is believed to be one of the reasons for its excellent biocompatibility and osteoconductive properties. The slow but finite dissolution rate of crystalline hydroxyapatite provides a continuous source of calcium and inorganic phosphate [18]. In our present study, as well as in those reported by others, bone often appears to be directly deposited on the hydroxyapatite coating without any intervening layer of fibrous tissue, the latter being more commonly seen in uncoated titanium surfaces [22,23,28,37]. While hydroxyapatite by itself is considered osteoconductive, in vivo the surface adsorption of proteins (such as bone morphogenetic proteins) may render the surface osteoinductive [38,39]. In addition, osteoblasts may attach and release active osteoinductive factors[18]. All of these factors combined may be responsible for the enhanced bone response.

Clinical outcomes have substantiated the results of this animal model. Early osseointegration and more stable implant-bone interfaces were seen radiographically. In patients implanted with hydroxyapatite-coated femoral stems, no evidence of mechanical failures or progressive radiolucencies was noted [40,41]. Evidence exists that hydroxyapatite provides benefits beyond promoting osseointegration and enhancing implant stability. More complete osseointegration may act as a barrier to the migration of polyethylene debris along the bone-implant interface thereby reducing the incidence of osteolysis [9,10,42,43]. Rahbek et al demonstrated that hydroxyapatite effectively prevented particle migration when compared to non-coated grit-blasted titanium alloy implants in a canine femoral model [10,43,44]. A ten-year clinical follow up of a hydroxyapatite-coated femoral stem did not find evidence of distal osteolysis despite relatively high polyethylene wear [41,45]. With current-generation implant designs, short-term stability is no longer a major issue [14,15,46,47]. Longer-term follow up, however, shows polyethylene wear and lysis to be a major concern [48-51]. Measures that directly reduce wear (such as crosslinked polyethylenes and alternative bearing surfaces) have been introduced with some success [52,53]. However, a higher level of osseointegration is also extremely valuable, because it can reduce the incidence of distal osteolysis, which is one of the primary causes of implant failure [41,48,54].

One limitation of the study was the use of only roughness parameter (Ra). Other roughness and surface parameters may also be important in determining potential for osseointegration. Osseointegration was only measured using one histomorphometric parameter (bone-to-implant contact). We did not measure the mechanical strength of the interface that is relevant for hip arthroplasty. However, others have correlated mechanical pull-out strength with the histomorphetric assessment of osseointegration [28].

Effective osseointegration of noncemented components plays an essential role in implant fixation, long-term stability, and survivorship. Our in vivo study evaluated the bone response to three surfaces, which adds to the body of evidence that is useful for optimizing the osseointegration of implants and enhancing fixation. It is important to identify factors that minimize joint arthroplasty failure and the significant physical and financial costs that failure represents. Finally, clinical outcomes studies are needed to validate the impact of implant surface and related osseointegration on THA outcomes.

Competing interests

Research funds in support of this study were provided to Scripps Clinic from Stryker Orthopaedics. Two of the authors are employees of Stryker Orthopaedics.

Authors' contributions

DDD, CWC, MH contributed to the conception and the study design. JCH, AB, MR participated in the data acquisition. DD and FD performed the data verification. FD, MH, CWC, DDD were involved in the data interpretation. JCH, MH, DDD contributed to the writing of the manuscript. All authors have read and approved the final manuscript.

References

  • Chmell MJ, Scott RD, Thomas WH, Sledge CB. Total hip arthroplasty with cement for juvenile rheumatoid arthritis. Results at a minimum of ten years in patients less than thirty years old. J Bone Joint Surg Am. 1997;79:44–52. [PubMed]
  • Garino JP, Steinberg ME. Total hip arthroplasty in patients with avascular necrosis of the femoral head: a 2- to 10-year follow-up. Clin Orthop Relat Res. 1997;334:108–115. doi: 10.1097/00003086-199701000-00014. [PubMed] [Cross Ref]
  • Malchau H, Wang YX, Karrholm J, Herberts P. Scandinavian multicenter porous coated anatomic total hip arthroplasty study. Clinical and radiographic results with 7- to 10-year follow-up evaluation. J Arthroplasty. 1997;12:133–148. doi: 10.1016/S0883-5403(97)90059-0. [PubMed] [Cross Ref]
  • Torchia ME, Klassen RA, Bianco AJ. Total hip arthroplasty with cement in patients less than twenty years old. Long-term results. J Bone Joint Surg Am. 1996;78:995–1003. doi: 10.1302/0301-620X78B6.7170. [PubMed] [Cross Ref]
  • Berry DJ, Harmsen WS, Ilstrup D, Lewallen DG, Cabanela ME. Survivorship of uncemented proximally porous-coated femoral components. Clin Orthop Relat Res. 1995;319:168–177. [PubMed]
  • Callaghan JJ, Tooma GS, Olejniczak JP, Goetz DD, Johnston RC. Primary hybrid total hip arthroplasty: an interim followup. Clin Orthop Relat Res. 1996;333:118–125. doi: 10.1097/00003086-199612000-00011. [PubMed] [Cross Ref]
  • D'Lima DD, Oishi CS, Petersilge WJ, Colwell CW Jr, Walker RH. 100 cemented versus 100 noncemented stems with comparison of 25 matched pairs. Clin Orthop Relat Res. 1998;348:140–148. [PubMed]
  • Dickob M, Martini T. The cementless PM hip arthroplasty. Four-to-seven-year results. J Bone Joint Surg Br. 1996;78:195–199. [PubMed]
  • Engh CA, Jr, Culpepper WJ, Engh CA. J Bone Joint Surg Am. 2. Vol. 79. 1997. Long-term results of use of the anatomic medullary locking prosthesis in total hip arthroplasty; pp. 177–184. [PubMed] [Cross Ref]
  • Petersilge WJ, D'Lima DD, Walker RH, Colwell CW Jr. Prospective study of 100 consecutive Harris-Galante porous total hip arthroplasties. 4- to 8-year follow-up study. J Arthroplasty. 1997;12:185–193. doi: 10.1016/S0883-5403(97)90065-6. [PubMed] [Cross Ref]
  • Stulberg BN, Singer R, Goldner J, Stulberg J. Uncemented total hip arthroplasty in osteonecrosis: a 2- to 10-year evaluation. Clin Orthop Relat Res. 1997;334:116–123. doi: 10.1097/00003086-199701000-00015. [PubMed] [Cross Ref]
  • D'Antonio JA, Capello WN, Crothers OD, Jaffe WL, Manley MT. Early clinical experience with hydroxyapatite-coated femoral implants. J Bone Joint Surg Am. 1992;74:995–1008. [PubMed]
  • D'Antonio JA, Capello WN, Manley MT. Remodeling of bone around hydroxyapatite-coated femoral stems. J Bone Joint Surg Am. 1996;78:1226–1234. [PubMed]
  • D'Lima DD, Walker RH, Colwell CW Jr. Omnifit-HA stem in total hip arthroplasty. A 2- to 5-year followup. Clin Orthop Relat Res. 1999;363:163–169. [PubMed]
  • Geesink RG, Hoefnagels NH. Six-year results of hydroxyapatite-coated total hip replacement. J Bone Joint Surg Br. 1995;77:534–547. [PubMed]
  • Harris WH. The problem is osteolysis. Clin Orthop Relat Res. 1995;311:46–53. [PubMed]
  • Kroon PO, Freeman MA. Hydroxyapatite coating of hip prostheses. Effect on migration into the femur. J Bone Joint Surg Br. 1992;74:518–522. [PubMed]
  • Beck GR Jr. Inorganic phosphate as a signaling molecule in osteoblast differentiation. J Cell Biochem. 2003;90:234–243. doi: 10.1002/jcb.10622. [PubMed] [Cross Ref]
  • Reddi AH. Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng. 2000;6:351–359. doi: 10.1089/107632700418074. [PubMed] [Cross Ref]
  • Michaels CM, Keller JC, Stanford CM, Solursh M. In vitro cell attachment of osteoblast-like cells to titanium. J Dental Res. 1989;68:276–282.
  • Curtis A, Clark P. The effects of topographical and mechanical properties of materials on cell behavior. CRC Crit Rev Biocompatibil. 1990;5:343–362.
  • D'Lima DD, Lemperle SM, Chen PC, Holmes RE, Colwell CW Jr. Bone response to implant surface morphology. J Arthroplasty. 1998;13:928–934. doi: 10.1016/S0883-5403(98)90201-7. [PubMed] [Cross Ref]
  • Feighan JE, Goldberg VM, Davy D, Parr JA, Stevenson S. The influence of surface-blasting on the incorporation of titanium-alloy implants in a rabbit intramedullary model. J Bone Joint Surg Am. 1995;77:1380–1395. [PubMed]
  • Wennerberg A, Albrektsson T, Johansson C, Andersson B. Experimental study of turned and grit-blasted screw-shaped implants with special emphasis on effects of blasting material and surface topography. Biomaterials. 1996;17:15–22. doi: 10.1016/0142-9612(96)80750-2. [PubMed] [Cross Ref]
  • Wong M, Eulenberger J, Schenk R, Hunziker E. Effect of surface topology on the osseointegration of implant materials in trabecular bone. J Biomed Mater Res. 1995;29:1567–1575. doi: 10.1002/jbm.820291213. [PubMed] [Cross Ref]
  • Hacking SA, Tanzer M, Harvey EJ, Krygier JJ, Bobyn JD. Relative contributions of chemistry and topography to the osseointegration of hydroxyapatite coatings. Clin Orthop Relat Res. 2002;405:24–38. doi: 10.1097/00003086-200212000-00004. [PubMed] [Cross Ref]
  • Daugaard H, Elmengaard B, Bechtold JE, Jensen T, Soballe K. The effect on bone growth enhancement of implant coatings with hydroxyapatite and collagen deposited electrochemically and by plasma spray. J Biomed Mater Res A. 2010;92:913–921. [PubMed]
  • Tisdel CL, Goldberg VM, Parr JA, Bensusan JS, Staikoff LS, Stevenson S. The influence of a hydroxyapatite and tricalcium-phosphate coating on bone growth into titanium fiber-metal implants. J Bone Joint Surg Am. 1994;76:159–171. [PubMed]
  • Holmes RE, Hagler HK, Coletta CA. Thick-section histometry of porous hydroxyapatite implants using backscattered electron imaging. J Biomed Mater Res. 1987;21:731–739. doi: 10.1002/jbm.820210605. [PubMed] [Cross Ref]
  • Buser D, Schenk RK, Steinemann S, Fiorellini JP, Fox CH, Stich H. Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J Biomed Mater Res. 1991;25:889–902. doi: 10.1002/jbm.820250708. [PubMed] [Cross Ref]
  • Gotfredsen K, Berglundh T, Lindhe J. Anchorage of titanium implants with different surface characteristics: an experimental study in rabbits. Clin Implant Dent Relat Res. 2000;2:120–128. doi: 10.1111/j.1708-8208.2000.tb00002.x. [PubMed] [Cross Ref]
  • Gotfredsen K, Wennerberg A, Johansson C, Skovgaard LT, Hjorting-Hansen E. Anchorage of TiO2-blasted, HA-coated, and machined implants: an experimental study with rabbits. J Biomed Mater Res. 1995;29:1223–1231. doi: 10.1002/jbm.820291009. [PubMed] [Cross Ref]
  • Darimont GL, Cloots R, Heinen E, Seidel L, Legrand R. In vivo behaviour of hydroxyapatite coatings on titanium implants: a quantitative study in the rabbit. Biomaterials. 2002;23:2569–2575. doi: 10.1016/S0142-9612(01)00392-1. [PubMed] [Cross Ref]
  • Gottlander M, Albrektsson T, Carlsson LV. A histomorphometric study of unthreaded hydroxyapatite-coated and titanium-coated implants in rabbit bone. Int J Oral Maxillofac Implants. 1992;7:485–490. [PubMed]
  • Soballe K. Hydroxyapatite ceramic coating for bone implant fixation. Mechanical and histological studies in dogs. Acta Orthop Scand Suppl. 1993;255:1–58. [PubMed]
  • Thomas KA, Kay JF, Cook SD, Jarcho M. The effect of surface macrotexture and hydroxylapatite coating on the mechanical strengths and histologic profiles of titanium implant materials. J Biomed Mater Res. 1987;21:1395–1414. doi: 10.1002/jbm.820211205. [PubMed] [Cross Ref]
  • Carlsson L, Regner L, Johansson C, Gottlander M, Herberts P. Bone response to hydroxyapatite-coated and commercially pure titanium implants in the human arthritic knee. J Orthop Res. 1994;12:274–285. doi: 10.1002/jor.1100120218. [PubMed] [Cross Ref]
  • Dong X, Wang Q, Wu T, Pan H. Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface. Biophys J. 2007;93:750–759. doi: 10.1529/biophysj.106.103168. [PubMed] [Cross Ref]
  • Autefage H, Briand-Mesange F, Cazalbou S, Drouet C, Fourmy D, Goncalves S, Salles JP, Combes C, Swider P, Rey C. Adsorption and release of BMP-2 on nanocrystalline apatite-coated and uncoated hydroxyapatite/beta-tricalcium phosphate porous ceramics. J Biomed Mater Res B Appl Biomater. 2009;91:706–715. [PubMed]
  • Hermida JC, Patil S, Colwell CW Jr, D'Lima DD. Bioceramic-implant coatings: correlation between animal and clinical studies. AAOS 72nd Annual Meeting. 2005;6
  • Lee GY, Srivastava A, D'Lima DD, Pulido PA, Colwell CW Jr. Hydroxyapatite-coated femoral stem survivorship at 10 years. J Arthroplasty. 2005;20:57–62. doi: 10.1016/j.arth.2005.04.022. [PubMed] [Cross Ref]
  • Bobyn JD, Jacobs JJ, Tanzer M, Urban RM, Aribindi R, Sumner DR, Turner TM, Brooks CE. The susceptibility of smooth implant surfaces to periimplant fibrosis and migration of polyethylene wear debris. Clin Orthop Relat Res. 1995;311:21–39. [PubMed]
  • McPherson EJ, Dorr LD, Gruen TA, Saberi MT. Hydroxyapatite-coated proximal ingrowth femoral stems. A matched pair control study. Clin Orthop Relat Res. 1995;315:223–230. [PubMed]
  • Rahbek O, Overgaard S, Lind M, Bendix K, Bunger C, Soballe K. Sealing effect of hydroxyapatite coating on peri-implant migration of particles. An experimental study in dogs. J Bone Joint Surg Br. 2001;83:441–447. doi: 10.1302/0301-620X.83B3.10667. [PubMed] [Cross Ref]
  • D'Antonio JA, Capello WN, Manley MT, Geesink R. Hydroxyapatite femoral stems for total hip arthroplasty: 10- to 13-year followup. Clin Orthop Relat Res. 2001;393:101–111. doi: 10.1097/00003086-200112000-00012. [PubMed] [Cross Ref]
  • Capello WN. Hydroxyapatite in total hip arthroplasty: five-year clinical experience. Orthopedics. 1994;17:781–792. [PubMed]
  • Capello WN, D'Antonio JS, Feinberg JR. Hydroxyapatite-coated stems in patients under 50 years old: clinical radiographic results at five-year minimum follow-up. Orthop Trans. 1995;19:399.
  • Capello WN, D'Antonio JA, Feinberg JR, Manley MT. Ten-year results with hydroxyapatite-coated total hip femoral components in patients less than fifty years old. A concise follow-up of a previous report. J Bone Joint Surg Am. 2003;85-A:885–889. [PubMed]
  • Herrera A, Canales V, Anderson J, Garcia-Araujo C, Murcia-Mazon A, Tonino AJ. Seven to 10 years followup of an anatomic hip prosthesis: an international study. Clin Orthop Relat Res. 2004;423:129–137. doi: 10.1097/01.blo.0000128973.73132.0b. [PubMed] [Cross Ref]
  • Reikeras O, Gunderson RB. Excellent results of HA coating on a grit-blasted stem: 245 patients followed for 8-12 years. Acta Orthop Scand. 2003;74:140–145. doi: 10.1080/00016470310013851. [PubMed] [Cross Ref]
  • Rokkum M, Brandt M, Bye K, Hetland KR, Waage S, Reigstad R. Polyethylene wear, osteolysis and acetabular loosening with an HA-coated hip prosthesis. A follow-up of 94 consecutive arthroplasties. J Bone Joint Surg Br. 1999;81:582–589. doi: 10.1302/0301-620X.81B4.8715. [PubMed] [Cross Ref]
  • Digas G, Karrholm J, Thanner J, Malchau H, Herberts P. The Otto Aufranc Award. Highly cross-linked polyethylene in total hip arthroplasty: randomized evaluation of penetration rate in cemented and uncemented sockets using radiostereometric analysis. Clin Orthop Relat Res. 2004;429:6–16. doi: 10.1097/01.blo.0000150314.70919.e3. [PubMed] [Cross Ref]
  • Muratoglu OK, Bragdon CR, O'Connor DO, Jasty M, Harris WH. A novel method of cross-linking ultra-high-molecular-weight polyethylene to improve wear, reduce oxidation, and retain mechanical properties. Recipient of the 1999 HAP Paul Award. J Arthroplasty. 2001;16:149–160. doi: 10.1054/arth.2001.20540. [PubMed] [Cross Ref]
  • Geesink RG. Osteoconductive coatings for total joint arthroplasty. Clin Orthop Relat Res. 2002;395:53–65. doi: 10.1097/00003086-200202000-00007. [PubMed] [Cross Ref]

Articles from Journal of Orthopaedic Surgery and Research are provided here courtesy of BioMed Central